Abstract

Consumption of coffee, tea and alcohol might be shaped by individual differences in bitter taste perception but inconsistent observational findings provide little insight regarding causality. We conducted Mendelian randomization analyses using genetic variants associated with the perception of bitter substances (rs1726866 for propylthiouracil [PROP], rs10772420 for quinine and rs2597979 for caffeine) to evaluate the intake of coffee, tea and alcohol among up to 438,870 UK Biobank participants. A standard deviation (SD) higher in genetically predicted bitterness of caffeine was associated with increased coffee intake (0.146 [95%CI: 0.103, 0.189] cups/day), whereas a SD higher in those of PROP and quinine was associated with decreased coffee intake (−0.021 [−0.031, −0.011] and −0.081 [−0.108, −0.054] cups/day respectively). Higher caffeine perception was also associated with increased risk of being a heavy (>4 cups/day) coffee drinker (OR 1.207 [1.126, 1.294]). Opposite pattern of associations was observed for tea possibly due to the inverse relationship between both beverages. Alcohol intake was only negatively associated with PROP perception (−0.141 [−1.88, −0.94] times/month per SD increase in PROP bitterness). Our results reveal that bitter perception is causally associated with intake of coffee, tea and alcohol, suggesting a role of bitter taste in the development of bitter beverage consumption.

Details

Title
Understanding the role of bitter taste perception in coffee, tea and alcohol consumption through Mendelian randomization
Author
Jue-Sheng, Ong 1   VIAFID ORCID Logo  ; Liang-Dar, Hwang 2   VIAFID ORCID Logo  ; Zhong, Victor W 3 ; An Jiyuan 4 ; Puya, Gharahkhani 4   VIAFID ORCID Logo  ; Breslin, Paul A, S 5   VIAFID ORCID Logo  ; Wright, Margaret J 6 ; Lawlor, Deborah A 7 ; Whitfield, John 4   VIAFID ORCID Logo  ; MacGregor, Stuart 4   VIAFID ORCID Logo  ; Martin, Nicholas G 4   VIAFID ORCID Logo  ; Cornelis, Marilyn C 3 

 QIMR Berghofer Medical Research Institute, Brisbane, Australia (GRID:grid.1049.c) (ISNI:0000 0001 2294 1395); School of Medicine, University of Queensland, Brisbane, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537) 
 QIMR Berghofer Medical Research Institute, Brisbane, Australia (GRID:grid.1049.c) (ISNI:0000 0001 2294 1395); School of Medicine, University of Queensland, Brisbane, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537); University of Queensland Diamantina Institute, University of Queensland, Brisbane, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537) 
 Northwestern University Feinberg School of Medicine, Department of Preventive Medicine, Chicago, USA (GRID:grid.16753.36) (ISNI:0000 0001 2299 3507) 
 QIMR Berghofer Medical Research Institute, Brisbane, Australia (GRID:grid.1049.c) (ISNI:0000 0001 2294 1395) 
 Monell Chemical Senses Center, Philadelphia, USA (GRID:grid.250221.6) (ISNI:0000 0000 9142 2735); School of Environmental and Biological Sciences, Rutgers University, Department of Nutritional Sciences, New Brunswick, USA (GRID:grid.430387.b) (ISNI:0000 0004 1936 8796) 
 University of Queensland, Queensland Brain Institute, Brisbane, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537); University of Queensland, Centre for Advanced Imaging, Brisbane, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537) 
 MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, UK (GRID:grid.5337.2) (ISNI:0000 0004 1936 7603); Bristol Medical School, University of Bristol, Population Health Science, Bristol, UK (GRID:grid.5337.2) (ISNI:0000 0004 1936 7603) 
Publication year
2018
Publication date
Dec 2018
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2314540756
Copyright
This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.